| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90d41c5c08b4cc27008c8d448154a71f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2812
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2006-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20ad15ae37f980ec544f6d70d1f87322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_969be4285157489cd311860285f9d718
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_917c91f58cf3b1f6aa21545ecb01e264
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99cb819332b41addfa13b8000d39c0d3 |
| publicationDate |
2008-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20080030673-A |
| titleOfInvention |
Efficacy Assay for Antibody Drug Ingredients That Bind Fc Receptors |
| abstract |
The present invention relates to a method for identifying the properties of antibodies suitable as potency assays for batch release of said pharmaceutical compositions, particularly for use when applying for drug marketing authorization for pharmaceutical compositions comprising antibodies. A provided assay is a method of determining the potency of a medicament comprising an FcR binding peptide, comprising measuring the binding of the FcR binding peptide of the medicament to the Fc receptor, wherein one or more actions of the FcR binding peptide of the medicament The mechanism is mediated through the binding of the FcR binding peptide of the drug product to the Fc receptor. |
| priorityDate |
2005-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |